AXIM Biotechnologies (AXIM) News Today $0.0045 0.00 (-2.17%) As of 09/19/2025 03:11 PM Eastern Add Compare Share Share Headlines Stock AnalysisChartSEC FilingsShort InterestBuy This Stock AXIM Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Axim Biotechnologies Files Pre-Submission With FDA for CLIA Waiver Pathway on Lactoferrin Point-of-Care Diagnostic TestJune 24, 2025 | finance.yahoo.comAXIM Biotechnologies, Inc. (AXIM) Latest Stock News & Headlines - Yahoo FinanceApril 25, 2025 | finance.yahoo.comNSDC partners with Axim Collaborative to enhance Open edX Platform, drive innovation in skill developmentMarch 26, 2025 | finance.yahoo.comBest Global Universities for Biotechnology and Applied MicrobiologyOctober 26, 2024 | usnews.comAXIM Biotechnologies Receives Medical Device Manufacturing LicenseMay 29, 2024 | finance.yahoo.comAXIM Biotechnologies, Inc. (AXIM)May 25, 2024 | finance.yahoo.comQueenmother of Upper Axim recognised for contributions towards educationMay 24, 2024 | msn.comAXIM Biotechnologies Inc AXIMMay 11, 2024 | morningstar.comMADPT Adaptive Biotechnologies CorporationApril 18, 2024 | seekingalpha.comAxim youth appeal for sports infrastructureApril 4, 2024 | msn.comVIDEO: AXIM Biotechnologies CEO Presents at Benzinga Virtual Healthcare Summit 2024March 27, 2024 | globenewswire.comWe Want Peaceful Elections – Axim YouthMarch 7, 2024 | msn.comAXIM® Biotechnologies’ Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 20, 2024 | finance.yahoo.comAXIM® Biotechnologies' Tear Based Testing Platform Continues to Gain Traction After Successful Clinical ValidationFebruary 20, 2024 | globenewswire.comAxim Fishermen Hail GovtFebruary 7, 2024 | msn.comMASLOC Trial: Daniel Axim Denies ChargesFebruary 6, 2024 | msn.comAXIM and Auer partner for dry eye disease assay productionDecember 21, 2023 | msn.comAXIM® Biotechnologies Partners With Leading Diagnostic Manufacturer Auer Precision to Scale Assay ProductionDecember 20, 2023 | finance.yahoo.comTullow builds 14-unit dormitory block for Axim Girls SHSDecember 11, 2023 | msn.comLLBO Lifeline Biotechnologies, Inc.December 1, 2023 | seekingalpha.comCollPlant Biotechnologies Ltd. (CLGN) Q3 2023 Earnings Call TranscriptDecember 1, 2023 | seekingalpha.comCourt Orders Mental Test For Axim In MASLOC TrialNovember 8, 2023 | msn.comAxim Fishermen Plead For More PremixNovember 1, 2023 | msn.comAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson's DiseaseSeptember 12, 2023 | stockhouse.comAXIM® Biotechnologies Develops First Non-Invasive, Rapid, Point-of-Care, Diagnostic Test for Parkinson’s DiseaseSeptember 12, 2023 | finance.yahoo.comAXIM - AXIM Biotechnologies, Inc.September 10, 2023 | finance.yahoo.comAXIM® Biotechnologies Receives Notice of U.S. Patent Allowance for Three Separate Patents Including Its Rapid Point of Care Neutralizing Antibody TestAugust 1, 2023 | finance.yahoo.comUpdate: AXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJuly 12, 2023 | finance.yahoo.comUpdate: AXIM Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJuly 12, 2023 | finance.yahoo.comAXIM® Biotechnologies Starts Shipping Revenue Generating IgE Diagnostic Validation Assays to Customers NationwideJuly 12, 2023 | finance.yahoo.comNV5's Newly Acquired Subsidiary Axim Pockets Contract From National Geospatial Intelligence AgencyJune 14, 2023 | markets.businessinsider.comAXIM Biotechnologies Announces Over 40 Initial Clinic Commitments for Its Full Diagnostic Assay Platform LaunchMay 24, 2023 | finance.yahoo.comAXIM® Biotechnologies Appoints Kurt Phinney as Chief Operating Officer to Drive Scaling and Optimization of Manufacturing UnitMay 23, 2023 | finance.yahoo.comiXCells Biotechnologies Expands CRISPR-Cas9 Cell Products and Genome Engineering ServicesMay 20, 2023 | businesswire.comVitiligo Drug Market Analysis and Growth Foresights till 2031May 16, 2023 | marketwatch.comAxim Galamsey Gang Prime Suspect ArrestedApril 23, 2023 | msn.comAXIM® Biotechnologies Commences Commercial Manufacturing of FDA-Cleared Proprietary Ocular Diagnostic AssaysApril 11, 2023 | finance.yahoo.comNzema East MCE assures public of peace, tranquility in AximApril 7, 2023 | msn.comCollPlant Biotechnologies Ltd. (CLGN) Q4 2022 Earnings Call TranscriptMarch 31, 2023 | seekingalpha.comIntroducing Axim Collaborative and the Appointment of Stephanie Khurana as Chief Executive OfficerMarch 30, 2023 | technews.tmcnet.comAxim Tartan Tracks ReadyMarch 29, 2023 | msn.comAdaptive Biotechnologies Shares Cross Above 200 DMAMarch 29, 2023 | nasdaq.comAxim Youth Centre Almost CompleteMarch 22, 2023 | msn.comMedical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further ExpansionMarch 14, 2023 | finance.yahoo.comAXIM® Biotechnologies Files Provisional Patent on Novel Methodology for Use in Optical Diagnostic Assay ManufacturingMarch 14, 2023 | finance.yahoo.comAXIM Biotechnologies Files Patent on Fentanyl Neutralizing Antibody Test, Applies for DEA License to Work With Controlled SubstanceJanuary 17, 2023 | finance.yahoo.comAXIM® Biotechnologies CEO Issues Letter to Shareholders; Reminds of Conference CallJanuary 11, 2023 | finance.yahoo.comAXIM® Biotechnologies Develops Novel Dual IgE/MMP-9 Rapid Ophthalmological Diagnostic Test; Files Provisional PatentDecember 13, 2022 | finance.yahoo.comAXIM Biotechnologies Commercial Partner Verséa Ophthalmics Highlights Benefits of AXIM’s Eye Diagnostic SolutionsDecember 6, 2022 | finance.yahoo.comChief Imam Storms Axim HometownDecember 5, 2022 | msn.com Get AXIM Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for AXIM and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AXIM Media Mentions By Week AXIM Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AXIM News Sentiment▼0.000.76▲Average Medical News Sentiment AXIM News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AXIM Articles This Week▼00▲AXIM Articles Average Week Get the Latest News and Ratings for AXIM and Related Stocks Enter your email address to receive the latest news and analysts' ratings for AXIM Biotechnologies and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies FFNTF News AIMDW News AGNPF News ALST News AZNCF News AVXT News BCTXW News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:AXIM) was last updated on 9/21/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AXIM Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share AXIM Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
